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Abstract
Introduction. Cryptococcosis in immunocompetent adults is a rare disease in Europe, mostly induced by members of the
Cryptococcus gattii species complex. The diagnosis can be challenging due to its rarity, unspecific symptoms and long
symptomless latency.
Case presentation. A 49-year-old woman with a three weeks history of headache was admitted to the hospital due to
discrete ataxia and impaired vision. Cranial magnetic resonance imaging (MRI) showed a contrast-enhancing mass in the
cerebellum. Further investigations detected a slight leukocytosis and a single subpleural nodule in the right inferior lung
lobe. The cerebral lesion was surgically removed, and a direct frozen section only showed an unspecific inflammation. In
the course of her admission she developed non-treatable cerebral edema and died ten days after surgical intervention.
Histopathological examination of the surgical specimen and postmortem evaluation of the lung and the cerebrum
demonstrated fungal elements. Molecular identification of the fungal elements in formalin-fixed paraffin-embedded tissue
lead to the diagnosis of cryptococcosis induced by C. gattii sensu lato. Molecular genetic analysis identified the involved
cryptococcal species as genotype AFLP6/VGII, recently described as Cryptococcus deuterogattii, which is known to be
endemic to the west-coast of Canada and the USA. Additional heteroanamnestic information revealed that she had spent
her holidays on Vancouver Island, Canada, two years before disease onset, indicating that infection during this stay seems
to be plausible.
Conclusion. Cryptococcosis due to C. deuterogattii is a rarely encountered fungal disease in Europe, not particularly
associated with immunodeficiency, and infection is likely to be contracted in endemic areas. Due to its rarity, long
symptomless latency, unspecific symptoms and misleading radiological features the diagnosis can be challenging.
Physicians need to be aware of this differential diagnosis in immunocompetent patients, as early adequate therapy can be
lifesaving.
INTRODUCTION
In Western Europe Cryptococcus gattii infections have
increased during the last two decades [1]. C. gattii can cause
severe systemic disease in immunocompromised and
immunocompetent hosts [2–4]. Cryptococcal yeasts usually
enter the host via the respiratory tract [2]. Pulmonary
symptoms as well as radiographic features and clinical
parameters are mostly unspecific and often lead to misdiag-
nosis [5]. Both Cryptococcus neoformans and C. gattii spe-
cies complexes show a high affinity for the central nervous
system [6]. The median incubation time is six to seven
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months [7, 8]. By using molecular techniques, such as
restriction fragment length polymorphism (RFLP), PCR fin-
gerprinting, multi-locus sequence typing (MLST) and
amplified fragment length polymorphism (AFLP) finger-
printing it was observed that C. gattii species complex can
be differentiated into five distinct genotypes [1]. Due to epi-
demiological, genetic and ecological differences the taxon-
omy of the C. neoformans/C. gattii species complexes have
been recently thoroughly revised and the five C. gattii spe-
cies complex genotypes were all raised to species as C. gattii
sensu stricto (genotype AFLP4/VGI), Cryptococcus bacillis-
porus (genotype AFLP5/VGIII), Cryptococcus deuterogattii
(genotype AFLP6/VGII), Cryptococcus tetragattii (genotype
AFLP7/VGIV) and Cryptococcus decagattii (genotype
AFLP10) [9]. The globally occurring species Cryptococcus
gattii s.s. and C. deuterogattii are often involved in disease
in apparently immunocompetent subjects, while the other
three species are geographically restricted and have a predi-
lection for immunocompromised hosts, mostly HIV-
infected individuals [9]. An ongoing outbreak in British
Columbia (Canada) that was first recognized in 1999 and
started on Vancouver Island, was found to be caused by the
rare genotype AFLP6/VGII (=C. deuterogattii). The out-
break expanded to the Pacific Northwest of the USA,
although different subgenotypes were involved [10, 11] and
has affected the health of hundreds of humans, and many
more animals living in that area [12, 13]. In Germany, less
than 25 hospitalizations for cryptococcosis are listed per
year with 3% documented C. gattii s.l. infections. As molec-
ular analysis identified that only half of the infections were
acquired abroad [1], identification of environmental niches
occupied by C. gattii s.l. in Germany is an important chal-
lenge to assess the associated risk of infection [14]. Here we
report a fatal case of cryptococcosis due to C. deuterogattii
infection that was likely to have been acquired on Vancou-
ver Island two years before the onset of disease.
CASE REPORT
A 49-year-old woman was hospitalized in the University
Hospital Halle/Saale, Germany, with an acute presentation
of headache, discrete ataxia and impaired vision. No epi-
sodes of pyrexia were reported. Serum inflammatory
markers were inconspicuous with only a slight leukocytosis
(14.53 Gpt l 1). Cranial magnetic resonance imaging (MRI)
revealed a contrast-enhancing lesion with surrounding
edema in the left cerebellum hemisphere next to the cerebel-
lar pedunculus (Fig. 1a, b). In addition, computed tomogra-
phy (CT) showed a small hyperintense subpleural nodule in
the right lower lung lobe (Fig. 1e). To rule out malignancy
the cerebellar lesion was surgically biopsied via a suboccipi-
tal craniotomy. A frozen section contained paucicellular
glial tissue without signs of malignancy, purulence or spe-
cific infection (Fig. 1c, d). Postoperatively, the patient devel-
oped cerebral edema with displacement and compression of
the fourth ventricle and the brainstem. Severe increase of
intracranial pressure required suboccipital craniotomy
and application of cerebrospinal fluid (CSF) drainage.
A microbiological examination of the liquor was not carried
out as there was no suspicion of an infection. Despite exten-
sive supportive care the clinical condition did not improve
and ten days after hospitalization the patient died. An
autopsy demonstrated a purulent pneumonia with punctum
maximum in the right inferior lung lobe. In addition, fur-
ther processing of the cerebral biopsy was undertaken,
including PAS and Grocott staining. These revealed the
image of cerebral cryptococcosis with presentation of typical
capsule, highlighted fungi next to a surrounding histiocyte-
rich inflammation with abundance of foam cells and a rare
lymphocytic infiltrate (Fig. 2a, b). The same pathogens
were also seen in the inflamed pulmonary tissue (Fig. 2c, d).
Cryptococcal DNA was amplified by a broad-range PCR
assay targeting the ITS2 region of the ribosomal DNA. The
amplicon was identified as C. gattii by LCD-Chip hybridiza-
tion (LCD array fungi 2.1; Chipron). Natural reservoirs for
C. gattii are found in Australia, Asia, Africa and some
regions of America, including Vancouver Island which has
been determined to be an endemic area [1]. In contrast,
infection in Europe is rare, although C. gattii has been previ-
ously isolated in Greece, southern Italy and Spain [15].
When confronted with the autopsy results the relatives of
the deceased mentioned that she spent her holidays on
Vancouver Island two years prior her death. Tissue samples
were transmitted to the Robert-Koch Institute (Berlin,
Germany) where molecular pathogen analysis was con-
firmed by amplification of the IGS region of the ribosomal
DNA with amplicon detection by LCD-Chip hybridization
using a commercial system (Chipron) and ITS2 PCR with
amplicon sequencing [16]. Subsequently in Nijmegen, the
Netherlands, a standard multi-locus sequence typing analy-
sis was performed [1], which did not yield any PCR product
due to the fragmented formalin-fixed paraffin-embedded
(FFPE)-DNA. Therefore a FFPE-MLST scheme was devel-
oped to cover the most variable parts of each of the seven
standard MLST-loci (Table 1). PCRs and sequencing were
performed as described previously [1]. Using the FFPE-
MLST it was determined that the involved cryptococcal
strain was C. deuterogattii, formerly known as C. gattii
genotype AFLP6/VGII. By using phylogenetic analysis, it
was determined that this strain clustered within the clade of
Vancouver-Island-outbreak-related C. deuterogattii strains
(Fig. 3), which supports the earlier suggestion that the
patient acquired the cryptococcal infection during her holi-
day to Vancouver Island.
DISCUSSION
Cryptococcus is a common yeast fungus with a natural reser-
voir on decaying wood and bird droppings [12–14]. Until
recently, the genus Cryptococcus included over 100 species,
but after a thorough taxonomic revision only ten remained
[9]. Members of the C. gattii species complex, which is com-
mon in Sub-Saharan Africa, Asia, Australia, Europe, South
and North America, can infect persons without immunode-
ficiency [2, 12, 13, 15–17]. As a diagnostic challenge, the
patients do not present typical clinical or laboratory
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findings. Furthermore, it has been reported that the infec-
tion first involves the pulmonary tract and spreads second-
arily to organs, especially the central nervous system [18].
Frequently, the patients present with a respiratory syn-
drome with cough, dyspnea and chest pain while neurologi-
cal symptoms, like headache and neck stiffness, as well as
night sweats, weight loss and anorexia may occur afterwards
[2]. Additionally, it has been reported that the clinical
symptoms and the progression of the disease differ between
species within the C. gattii species complex [12, 18–20],
even in vitro antifungal susceptibility varies [21]. Concern-
ing the case presented here, a woman with cough over a
period longer than one year suddenly developed acute head-
ache, discrete ataxia and impaired vision. Initially, the
blurred mass in the cerebellum together with the subpleural
nodule in the right lower lung lobe was misinterpreted as
Fig. 1. Preoperative and intraoperative diagnostic investigations. Cranial magnetic resonance imaging (a and b) showing a circum-
scribed mass in the left cerebellum hemisphere (arrows). Further investigations included a chest computed tomography (e) with pre-
sentation of a subpleural nodule in the right lower lobe (arrow). An intraoperative frozen section (c and d) revealed paucicellular glial
tissue with several infiltrating immune cells.
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malignancy, a finding that is described in several other
reports [5, 13, 18, 21–25]. The hypothesis of malignancy
was further supported by clinical and laboratory findings, as
the patient had no fever and only mild leukocytosis. Finally,
the diagnosis of cryptococcosis was only made post mortem
after histopathological and molecular-pathological evalua-
tion. A main reason for the delayed diagnosis is the lack of
experience due to the low incidence in an unexpected
patient group. It should also be noted that the time between
infection and the first clinical symptoms was uncommonly
long, compared with a reported median incubation time of
between six and seven months [7, 8]. According to data
from the Robert Koch Institute in Berlin, Germany, only
three percent of 155 cases of cryptococcosis were related to
C gattii s.l. between 2004 and 2013 [13, 14] and surveillance
is challenging because fungal infections are not notifiable
diseases. The available data indicate that there was no signif-
icant increase of cryptococcosis during that period [14].
However, in terms of health policy it is meaningful that
C. gattii s.l. infections might also occur in Northern Europe,
probably as a consequence of climate change [14, 26].
Therefore, nowadays this fungal pathogen is not only
restricted to tropical and subtropical regions [14] and
endemic areas for C. gattii s.l. within Europe have been
described [1]. In 2012 the fungus was isolated from a tree in
the Netherlands [27] and earlier C. gattii s.l. was detected in
Italy, Greece, Portugal, and Spain [1, 15, 21, 28]. Further-
more, in Germany few cases of cryptococcosis due to C. gat-
tii s.s. without a travel history to endemic regions have been
documented [14]. Nonetheless at least half of the infections
in Germany were acquired abroad [1, 14]. In summary, it is
important that clinicians are aware of this challenging inva-
sive mycosis that often infects immunocompetent subjects.
Unspecific symptoms with cough in conjunction with acute
cerebral symptoms are indicators for the diagnosis and it
Fig. 2. Postmortem diagnostic investigations. Cerebellar tissue (a and
b) showing single immune cells next to some poorly demarcating
spherules in HE-staining. Assessment of lung tissue (c and d) revealed
a purulent pneumonia with presentation of several foci with the same
round and oval structures (Arrows). Further staining of the cerebellar
tissue as well as of the lung tissue including PAS reaction and Grocott
staining supported the assumption that this was due to Cryptococcus.
Table 1. Newly designed Cryptococcus gattii sensu lato FFPE-MLST
primers
Locus Primer name Primer sequence*
CAP59 FFPE-CAP59Fwd AGGCGAGGCAGCACAAGTA
FFPE-CAP59Rvd TTTGTCTGGTCGTTGGAACC
GPD1 FFPE-GPD1Fwd AGGTCGTATCGGTCGAATTG
FFPE-GPD1Rvd CCATGTAGTCCAAGTCAATGAAA
IGS1 FFPE-IGS1Fwd TTGGCTAAGATGCGTTATGC
FFPE-IGS1Rvd TTGCTTGACCGAGCTTGACT
LAC1 FFPE-LAC1Fwd CATGGTATGCGGCAGAAG
FFPE-LAC1Rvd AAGCCTATGGTACSTCATCAGC
PLB1 FFPE-PLB1Fwd CGTGGATTAGAAATGCCACTGT
FFPE-PLB1Rvd TTCGGTGCTTTCATTCATCA
SOD1 FFPE-SOD1Fwd ACTCTGAGAGGCACGTTGGT
FFPE-SOD1Rvd TGATGGAGTAAGGGCCAAAG
URA5 FFPE-URA5Fwd AGGCCGGTGAGCCATATC
FFPE-URA5Rvd CGTCCTTCTTCTCCTTCCTG
*All primers have a Tm of 60

C, PCRs were performed as described
previously [1].
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has to be pointed out that an early diagnosis allows cure of
the majority of patients, albeit that despite effective treat-
ment central nervous complications may persist [6].
Conclusion
In Western Europe, increased international travel leads to a
rising number of infections with rare pathogens [29]. Addi-
tionally climate change creates new ecological niches in the
environment. C. gattii, which has been formerly known to
be a pathogen in tropical and subtropical regions [2, 3], has
been recognized in temperate regions in Europe and North
America [1, 10, 15]. In consequence of the lack of experi-
ence due to the low incidence in a particularly unexpected
group of patients, determination of the diagnosis is often
delayed and findings are misinterpreted [13, 14]. Early
diagnosis is critical for a successful treatment of this other-
wise lethal infection mostly due to central nervous compli-
cations [6].
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Fig. 3. Phylogenetic analysis Using phylogenetic analysis, it was observed that this strain clustered within the clade of Vancouver-
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